Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA

por Ionova, Yelena, Vuong, Wilson, Sandoval, Omar, Fong, Jodie, Vu, Vincent, Zhong, Lixian, Wilson, Leslie
Publicado 2022